Efficacy and Safety of Cryoballoon Ablation in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction　― A Multicenter Study ―-Reference-Cited by-同舟云学术

Efficacy and Safety of Cryoballoon Ablation in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction　― A Multicenter Study ―

Published:2019-07-25 Issue:8 Volume:83 Page:1653-1659
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Heeger Christian-Hendrik¹²,Abdin Amr²,Mathew Shibu¹,Reissmann Bruno¹,Yalin Kivanc²,Liosis Spyridon²,Fink Thomas¹²,Proietti Riccardo²,Eitel Charlotte²,Vogler Julia²,Lemeš Christine¹,Maurer Tilman¹,Rillig Andreas¹,Meyer-Saraei Roza²,Graf Tobias²,Wohlmuth Peter¹,Goldmann Britta³,Ouyang Feifan¹,Kuck Karl-Heinz¹,Metzner Andreas¹³,Tilz Roland Richard²

Affiliation:

1. Department of Cardiology, Asklepios Klinik St. Georg

2. University Heart Center Luebeck, Medical Clinic II (Department of Cardiology, Angiology and Intensive Care Medicine), Sektion Elektropjysiologie, University Hospital Schleswig-Holstein

3. Department of Cardiology, Asklepios Klinik Harburg

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/83/8/83_CJ-19-0151/_pdf

Reference22 articles.

1. 1. Anter E, Jessup M, Callans DJ. Atrial fibrillation and heart failure: Treatment considerations for a dual epidemic. Circulation 2009; 119: 2516–2525.

2. 2. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials [Studies of Left Ventricular Dysfunction]. J Am Coll Cardiol 1998; 32: 695–703.

3. 3. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920–2925.

4. 4. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: Results from the AATAC Multicenter Randomized Trial. Circulation 2016; 133: 1637–1644.

5. 5. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378: 417–427.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of cryoballoon atrial fibrillation ablation in patients with heart failure: A systematic review and meta-analysis;Indian Pacing and Electrophysiology Journal;2024-01

2. Cryoballoon ablation for atrial fibrillation in patients with heart failure and reduced left ventricular ejection fraction: A systematic review and meta‐analysis;Clinical Cardiology;2023-10-25

3. Catheter Ablation Approaches for the Treatment of Arrhythmia Recurrence in Patients with a Durable Pulmonary Vein Isolation;Balkan Medical Journal;2023-10-20

4. Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction;ESC Heart Failure;2022-11-03

5. Efficacy and feasibility of cryoballoon ablation for atrial fibrillation in patients with heart failure: A large‐scale multicenter study;Journal of Cardiovascular Electrophysiology;2022-10-05